Asymmetrex® is a non-federal biotechnology company focused on stem cell-based medicines using novel adult stem cell technology. The objective of the Asymmetrex® technology is to pave the way for innovative growth of stem cell medicine. The company offers four different -types of services, namely, Tortoise test, Rabbit count, and Potency tests for tissue-specific stem cells and provides suppression of asymmetric cell kinetic (SACK)- expended human tissue stem cells. For more information, please visit https://asymmetrex.com/